Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Frank

Showing results (81-90 of 129) with videos related to

Pageof 13
Sort By:
Nature|June 20, 2020
Retraction Note: Fatty acids and cancer-amplified ZDHHC19 promote STAT3 activation through S-palmitoylationJixiao Niu, Yang Sun, Baoen Chen, et al.
Nature Genetics|January 15, 2013
Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumorsJuliann Chmielecki, Aimee M Crago, Mara Rosenberg, et al.
Cancer Immunology, Immunotherapy : CII|September 7, 2017
The STAT3 inhibitor pyrimethamine displays anti-cancer and immune stimulatory effects in murine models of breast cancerMohammad W Khan, Abdulrahman Saadalla, Ahmed H Ewida, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 6, 2008
Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasivenessNúria de la Iglesia, Genevieve Konopka, Kah-Leong Lim, et al.
Cancer Cytopathology|December 17, 2015
Young investigator challenge: Application of cytologic techniques to circulating tumor cell specimens: Detecting activation of the oncogenic transcription factor STAT3Alarice C Lowe, Jean-Christophe Pignon, Ingrid Carvo, et al.
Blood|April 29, 2006
IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivoEmmanuel Zorn, Erik A Nelson, Mehrdad Mohseni, et al.
Neoplasia (New York, N.Y.)|November 26, 2019
CDK5RAP3 is a co-factor for the oncogenic transcription factor STAT3Susana P Egusquiaguirre, Suhu Liu, Isidora Tošić, et al.
Molecular Cancer Therapeutics|January 18, 2014
Targeting STAT5 in hematologic malignancies through inhibition of the bromodomain and extra-terminal (BET) bromodomain protein BRD2Suhu Liu, Sarah R Walker, Erik A Nelson, et al.
Breast Cancer Research : BCR|March 7, 2023
Prolactin levels and breast cancer risk by tumor expression of prolactin-related markersCassandra A Hathaway, Megan S Rice, Laura C Collins, et al.
JAMA Network Open|October 29, 2025
Health-Related Social Needs Among LGB+ VeteransShane Lamba, David A Frank, Jennifer L McCoy, et al.
Pageof 13

Showing results (81-90 of 129) with videos related to

Sort By:
Pageof 13
Nature|June 20, 2020
Retraction Note: Fatty acids and cancer-amplified ZDHHC19 promote STAT3 activation through S-palmitoylationJixiao Niu, Yang Sun, Baoen Chen, et al.
Nature Genetics|January 15, 2013
Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumorsJuliann Chmielecki, Aimee M Crago, Mara Rosenberg, et al.
Cancer Immunology, Immunotherapy : CII|September 7, 2017
The STAT3 inhibitor pyrimethamine displays anti-cancer and immune stimulatory effects in murine models of breast cancerMohammad W Khan, Abdulrahman Saadalla, Ahmed H Ewida, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 6, 2008
Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasivenessNúria de la Iglesia, Genevieve Konopka, Kah-Leong Lim, et al.
Cancer Cytopathology|December 17, 2015
Young investigator challenge: Application of cytologic techniques to circulating tumor cell specimens: Detecting activation of the oncogenic transcription factor STAT3Alarice C Lowe, Jean-Christophe Pignon, Ingrid Carvo, et al.
Blood|April 29, 2006
IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivoEmmanuel Zorn, Erik A Nelson, Mehrdad Mohseni, et al.
Neoplasia (New York, N.Y.)|November 26, 2019
CDK5RAP3 is a co-factor for the oncogenic transcription factor STAT3Susana P Egusquiaguirre, Suhu Liu, Isidora Tošić, et al.
Molecular Cancer Therapeutics|January 18, 2014
Targeting STAT5 in hematologic malignancies through inhibition of the bromodomain and extra-terminal (BET) bromodomain protein BRD2Suhu Liu, Sarah R Walker, Erik A Nelson, et al.
Breast Cancer Research : BCR|March 7, 2023
Prolactin levels and breast cancer risk by tumor expression of prolactin-related markersCassandra A Hathaway, Megan S Rice, Laura C Collins, et al.
JAMA Network Open|October 29, 2025
Health-Related Social Needs Among LGB+ VeteransShane Lamba, David A Frank, Jennifer L McCoy, et al.
Pageof 13